MovDisordV3, Istex, Curation, bibRecord, 002A07

Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients

Identifieur interne : 002A07 ( Istex/Curation ); précédent : 002A06; suivant : 002A08

Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients

Auteurs : Paolo Lamberti [Italie] ; Stefano Zoccolella [Italie] ; Giovanni Iliceto [Italie] ; Elio Armenise [Italie] ; Angela Fraddosio [Italie] ; Michele De Mari [Italie] ; Paolo Livrea [Italie]

Source :

Movement Disorders [ 0885-3185 ] ; 2005-01.

RBID : ISTEX:059344931BC5E86B701FB0820B8FB0F10271CDBE

English descriptors

KwdEn :
- COMT inhibitors, Parkinson's disease, homocysteine, levodopa.

Abstract

Homocysteine (Hcy) is a risk factor for vascular diseases, cognitive impairment, and dementia. Elevated plasma concentrations of Hcy have been found recently in Parkinson's disease (PD) patients treated with levodopa, suggesting that levodopa is a cause of hyperhomocysteinemia (HHcy). The mechanism underlying HHcy in PD is the O‐methylation of levodopa catalyzed by catechol‐O‐methyltransferase (COMT) that produces S‐adenosylhomocysteine, which is hydrolyzed rapidly to Hcy. COMT inhibitors (COMT‐I) are used currently in the treatment of PD; however, no study has assessed the effects of COMT‐I administration on Hcy concentrations in PD patients. We compared plasma levels of Hcy, B12, and folate in 26 PD patients treated with levodopa, 20 PD patients treated with levodopa + COMT‐I, and 32 controls. No significant differences were found in vitamin B12 levels, whereas folate concentrations were significantly lower in the levodopa‐treated group. Plasma Hcy was increased significantly in the two groups of PD patients and was significantly lower in the group treated with levodopa + COMT‐I. Statistical analysis showed that the difference in mean Hcy levels observed among PD patients was related to the addition of COMT‐I, rather than to folate concentrations. We conclude that levodopa treatment increases plasma Hcy and the addition of COMT‐I effectively reduces HHcy. © 2004 Movement Disorder Society

Url:

https://api.istex.fr/document/059344931BC5E86B701FB0820B8FB0F10271CDBE/fulltext/pdf

DOI: 10.1002/mds.20261

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002A07

Links to Exploration step

ISTEX:059344931BC5E86B701FB0820B8FB0F10271CDBE

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients</title>
<author><name sortKey="Lamberti, Paolo" sort="Lamberti, Paolo" uniqKey="Lamberti P" first="Paolo" last="Lamberti">Paolo Lamberti</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurological Sciences, University of Bari, Bari, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neurological Sciences, University of Bari, Bari</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zoccolella, Stefano" sort="Zoccolella, Stefano" uniqKey="Zoccolella S" first="Stefano" last="Zoccolella">Stefano Zoccolella</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurological Sciences, University of Bari, Bari, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neurological Sciences, University of Bari, Bari</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Iliceto, Giovanni" sort="Iliceto, Giovanni" uniqKey="Iliceto G" first="Giovanni" last="Iliceto">Giovanni Iliceto</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurological Sciences, University of Bari, Bari, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neurological Sciences, University of Bari, Bari</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Armenise, Elio" sort="Armenise, Elio" uniqKey="Armenise E" first="Elio" last="Armenise">Elio Armenise</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Internal Medicine and Public Health‐Hygiene Section, University of Bari, Bari, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Internal Medicine and Public Health‐Hygiene Section, University of Bari, Bari</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fraddosio, Angela" sort="Fraddosio, Angela" uniqKey="Fraddosio A" first="Angela" last="Fraddosio">Angela Fraddosio</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurological Sciences, University of Bari, Bari, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neurological Sciences, University of Bari, Bari</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="De Mari, Michele" sort="De Mari, Michele" uniqKey="De Mari M" first="Michele" last="De Mari">Michele De Mari</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurological Sciences, University of Bari, Bari, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neurological Sciences, University of Bari, Bari</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Livrea, Paolo" sort="Livrea, Paolo" uniqKey="Livrea P" first="Paolo" last="Livrea">Paolo Livrea</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurological Sciences, University of Bari, Bari, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neurological Sciences, University of Bari, Bari</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:059344931BC5E86B701FB0820B8FB0F10271CDBE</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/mds.20261</idno>
<idno type="url">https://api.istex.fr/document/059344931BC5E86B701FB0820B8FB0F10271CDBE/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002A07</idno>
<idno type="wicri:Area/Istex/Curation">002A07</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients</title>
<author><name sortKey="Lamberti, Paolo" sort="Lamberti, Paolo" uniqKey="Lamberti P" first="Paolo" last="Lamberti">Paolo Lamberti</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurological Sciences, University of Bari, Bari, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neurological Sciences, University of Bari, Bari</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zoccolella, Stefano" sort="Zoccolella, Stefano" uniqKey="Zoccolella S" first="Stefano" last="Zoccolella">Stefano Zoccolella</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurological Sciences, University of Bari, Bari, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neurological Sciences, University of Bari, Bari</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Iliceto, Giovanni" sort="Iliceto, Giovanni" uniqKey="Iliceto G" first="Giovanni" last="Iliceto">Giovanni Iliceto</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurological Sciences, University of Bari, Bari, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neurological Sciences, University of Bari, Bari</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Armenise, Elio" sort="Armenise, Elio" uniqKey="Armenise E" first="Elio" last="Armenise">Elio Armenise</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Internal Medicine and Public Health‐Hygiene Section, University of Bari, Bari, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Internal Medicine and Public Health‐Hygiene Section, University of Bari, Bari</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fraddosio, Angela" sort="Fraddosio, Angela" uniqKey="Fraddosio A" first="Angela" last="Fraddosio">Angela Fraddosio</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurological Sciences, University of Bari, Bari, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neurological Sciences, University of Bari, Bari</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="De Mari, Michele" sort="De Mari, Michele" uniqKey="De Mari M" first="Michele" last="De Mari">Michele De Mari</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurological Sciences, University of Bari, Bari, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neurological Sciences, University of Bari, Bari</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Livrea, Paolo" sort="Livrea, Paolo" uniqKey="Livrea P" first="Paolo" last="Livrea">Paolo Livrea</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurological Sciences, University of Bari, Bari, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neurological Sciences, University of Bari, Bari</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-01">2005-01</date>
<biblScope unit="vol">20</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="69">69</biblScope>
<biblScope unit="page" to="72">72</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">059344931BC5E86B701FB0820B8FB0F10271CDBE</idno>
<idno type="DOI">10.1002/mds.20261</idno>
<idno type="ArticleID">MDS20261</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>COMT inhibitors</term>
<term>Parkinson's disease</term>
<term>homocysteine</term>
<term>levodopa</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Homocysteine (Hcy) is a risk factor for vascular diseases, cognitive impairment, and dementia. Elevated plasma concentrations of Hcy have been found recently in Parkinson's disease (PD) patients treated with levodopa, suggesting that levodopa is a cause of hyperhomocysteinemia (HHcy). The mechanism underlying HHcy in PD is the O‐methylation of levodopa catalyzed by catechol‐O‐methyltransferase (COMT) that produces S‐adenosylhomocysteine, which is hydrolyzed rapidly to Hcy. COMT inhibitors (COMT‐I) are used currently in the treatment of PD; however, no study has assessed the effects of COMT‐I administration on Hcy concentrations in PD patients. We compared plasma levels of Hcy, B12, and folate in 26 PD patients treated with levodopa, 20 PD patients treated with levodopa + COMT‐I, and 32 controls. No significant differences were found in vitamin B12 levels, whereas folate concentrations were significantly lower in the levodopa‐treated group. Plasma Hcy was increased significantly in the two groups of PD patients and was significantly lower in the group treated with levodopa + COMT‐I. Statistical analysis showed that the difference in mean Hcy levels observed among PD patients was related to the addition of COMT‐I, rather than to folate concentrations. We conclude that levodopa treatment increases plasma Hcy and the addition of COMT‐I effectively reduces HHcy. © 2004 Movement Disorder Society</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002A07 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 002A07 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Istex
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:059344931BC5E86B701FB0820B8FB0F10271CDBE
   |texte=   Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients

Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri